Publication | Closed Access
AVX-470, an Orally Delivered Anti-Tumour Necrosis Factor Antibody for Treatment of Active Ulcerative Colitis: Results of a First-in-Human Trial
71
Citations
17
References
2016
Year
This trial was registered with Clinicaltrials.gov as study NCT01759056 and with EudraCT as study 2012-004859-27.
| Year | Citations | |
|---|---|---|
Page 1
Page 1